Inaugurating the Centre for Advanced Genomics and Precision Medicine at AIIMS in Jammu, Union minister Jitendra Singh says ...

Don’t look now, but Cathie Wood of Ark Invest is fresh off an impressive comeback year, with her broader basket of disruptive ...

The three-day event, held at the University of Hyderabad, brought together leading researchers from India and abroad to ...

India under Prime Minister Narendra Modi’s leadership prioritises technology-driven progress in the healthcare sector, Union minister Jitendra Singh said on Sunday. He reaffirmed the government’s ...

The strategic alliance is part of a shared vision to pioneer innovations and advance healthcare for the region and beyond; As part of this alliance, M42 has formally signed its fi ...

MIT chemists use generative AI to predict 3D genomic structures quickly, a process far faster than current methods.

Union Minister Dr Jitendra Singh on Sunday inaugurated the Centre for Advanced Genomics & Precision Medicine at the AIIMS ...

Q4 2024 Earnings Call Transcript January 31, 2025 Revvity, Inc. misses on earnings expectations. Reported EPS is $0.778 EPS, expectations were $1.37. Operator: Hello, everyone, and welcome to ...

London – M42, a global health leader powered by artificial intelligence (AI), and Hikma Pharmaceuticals PLC (Hikma), ...

New research pinpoints 298 parts of the genome associated with higher risk of bipolar disorder. This could lead to better ...

The life sciences business is characterized by demands in preclinical discovery and research. Revvity has been able to offer a more complete workflow to customers in this segment, building off the ...

The firm reported that its full-year 2024 revenues were up slightly as a rise in the diagnostics business was mostly offset by a decline in life sciences business.